1. Home
  2. PCSA vs TOMZ Comparison

PCSA vs TOMZ Comparison

Compare PCSA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$0.27

Market Cap

14.7M

Sector

Health Care

ML Signal

HOLD

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.78

Market Cap

17.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
TOMZ
Founded
2011
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
17.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PCSA
TOMZ
Price
$0.27
$0.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$1.00
$3.50
AVG Volume (30 Days)
1.1M
18.0K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,688,341.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$68.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.63
52 Week High
$1.50
$1.50

Technical Indicators

Market Signals
Indicator
PCSA
TOMZ
Relative Strength Index (RSI) 48.05 49.59
Support Level $0.27 $0.78
Resistance Level $0.30 $0.83
Average True Range (ATR) 0.02 0.03
MACD 0.00 0.01
Stochastic Oscillator 62.34 72.16

Price Performance

Historical Comparison
PCSA
TOMZ

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

Share on Social Networks: